These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 21677875)

  • 1. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.
    van der Horst G; van den Hoogen C; Buijs JT; Cheung H; Bloys H; Pelger RC; Lorenzon G; Heckmann B; Feyen J; Pujuguet P; Blanque R; Clément-Lacroix P; van der Pluijm G
    Neoplasia; 2011 Jun; 13(6):516-25. PubMed ID: 21677875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
    Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
    Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer.
    van den Hoogen C; van der Horst G; Cheung H; Buijs JT; Pelger RC; van der Pluijm G
    Am J Pathol; 2011 Nov; 179(5):2559-68. PubMed ID: 21907176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of a Histone Deacetylase Inhibitor (AR-42) on Canine Prostate Cancer Growth and Metastasis.
    Elshafae SM; Kohart NA; Altstadt LA; Dirksen WP; Rosol TJ
    Prostate; 2017 May; 77(7):776-793. PubMed ID: 28181686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer cells home to bone using a novel in vivo model: modulation by the integrin antagonist GLPG0187.
    Reeves KJ; Hurrell JE; Cecchini M; van der Pluijm G; Down JM; Eaton CL; Hamdy F; Clement-Lacroix P; Brown NJ
    Int J Cancer; 2015 Apr; 136(7):1731-40. PubMed ID: 25156971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of alpha-v integrins reduces malignancy of bladder carcinoma.
    van der Horst G; Bos L; van der Mark M; Cheung H; Heckmann B; Clément-Lacroix P; Lorenzon G; Pelger RC; Bevers RF; van der Pluijm G
    PLoS One; 2014; 9(9):e108464. PubMed ID: 25247809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.
    Mohamedali KA; Li ZG; Starbuck MW; Wan X; Yang J; Kim S; Zhang W; Rosenblum MG; Navone NM
    Clin Cancer Res; 2011 Apr; 17(8):2328-38. PubMed ID: 21343372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs.
    Huang S; He P; Peng X; Li J; Xu D; Tang Y
    Cell Physiol Biochem; 2015; 37(1):253-68. PubMed ID: 26302893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.
    Zuo J; Guo Y; Peng X; Tang Y; Zhang X; He P; Li S; Wa Q; Li J; Huang S; Xu D
    Oncol Rep; 2015 Mar; 33(3):1388-94. PubMed ID: 25571882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis.
    van den Hoogen C; van der Horst G; Cheung H; Buijs JT; Pelger RC; van der Pluijm G
    Clin Exp Metastasis; 2011 Oct; 28(7):615-25. PubMed ID: 21647815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer.
    Han Z; Wang X; Ma L; Chen L; Xiao M; Huang L; Cao Y; Bai J; Ma D; Zhou J; Hong Z
    Oncotarget; 2014 Sep; 5(18):8416-28. PubMed ID: 25261365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of S100A4 for bone metastasis in prostate cancer cells.
    Kim B; Jung S; Kim H; Kwon JO; Song MK; Kim MK; Kim HJ; Kim HH
    BMC Cancer; 2021 Feb; 21(1):137. PubMed ID: 33549040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fu-Zheng-Yi-Liu Formula inhibits the stem cells and metastasis of prostate cancer via tumor-associated macrophages/C-C motif chemokine ligand 5 pathway in tumor microenvironment.
    Chen C; Huang R; Wang N; Zheng Y; Zhou J; Yang B; Wang X; Zhang J; Pan B; Chen Z; Wang S; Wang Z; Xiang S
    Chin J Nat Med; 2024 Jun; 22(6):501-514. PubMed ID: 38906598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
    Ciardiello C; Leone A; Lanuti P; Roca MS; Moccia T; Minciacchi VR; Minopoli M; Gigantino V; De Cecio R; Rippa M; Petti L; Capone F; Vitagliano C; Milone MR; Pucci B; Lombardi R; Iannelli F; Di Gennaro E; Bruzzese F; Marchisio M; Carriero MV; Di Vizio D; Budillon A
    J Exp Clin Cancer Res; 2019 Jul; 38(1):317. PubMed ID: 31319863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis.
    Rabbani SA; Valentino ML; Arakelian A; Ali S; Boschelli F
    Mol Cancer Ther; 2010 May; 9(5):1147-57. PubMed ID: 20423991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Identification of Small Molecule Inhibitors That Reduce Invasion and Metastasis of Aggressive Cancers.
    van de Merbel AF; van Hooij O; van der Horst G; van Rijt-van de Westerlo CCM; van der Mark MH; Cheung H; Kroon J; Verhaegh GW; Tijhuis J; Wellink A; Maas P; Viëtor H; Schalken JA; van der Pluijm G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
    Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
    Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
    Baruah MM; Khandwekar AP; Sharma N
    Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer.
    Shang Z; Cai Q; Zhang M; Zhu S; Ma Y; Sun L; Jiang N; Tian J; Niu X; Chen J; Sun Y; Niu Y
    Oncotarget; 2015 Jan; 6(2):1202-16. PubMed ID: 25483103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
    Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
    J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.